Reported Earnings • May 08
First quarter 2026 earnings released: RM0.054 loss per share (vs RM0.055 loss in 1Q 2025) First quarter 2026 results: RM0.054 loss per share (improved from RM0.055 loss in 1Q 2025). Revenue: RM2.53b (up 70% from 1Q 2025). Net loss: RM122.7m (loss narrowed 2.4% from 1Q 2025). Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has fallen by 26% per year whereas the company’s share price has fallen by 31% per year. Announcement • Apr 23
Lotte Chemical Titan Holding Berhad, Annual General Meeting, May 25, 2026 Lotte Chemical Titan Holding Berhad, Annual General Meeting, May 25, 2026, at 10:00 Singapore Standard Time. Location: meeting room 2, level 2, renaissance johor bahru hotel, 2 jalan permas 11, bandar baru permas jaya, 81750 masai, johor darul takzim, Malaysia Major Estimate Revision • Apr 07
Consensus revenue estimates decrease by 26%, EPS upgraded The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from RM7.27b to RM5.35b. EPS estimate increased from -RM0.495 to -RM0.439 per share. Chemicals industry in Malaysia expected to see average net income growth of 26% next year. Consensus price target up from RM0.32 to RM0.37. Share price fell 9.1% to RM0.35 over the past week. New Risk • Mar 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change). Reported Earnings • Feb 26
Full year 2025 earnings released: RM0.94 loss per share (vs RM0.56 loss in FY 2024) Full year 2025 results: RM0.94 loss per share (further deteriorated from RM0.56 loss in FY 2024). Revenue: RM7.94b (up 6.8% from FY 2024). Net loss: RM2.14b (loss widened 69% from FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 3.9% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has fallen by 40% per year, which means it is performing significantly worse than earnings. Price Target Changed • Feb 26
Price target decreased by 11% to RM0.36 Down from RM0.41, the current price target is an average from 3 analysts. New target price is 20% above last closing price of RM0.30. Stock is down 32% over the past year. The company is forecast to post a net loss per share of RM0.32 next year compared to a net loss per share of RM0.55 last year. Major Estimate Revision • Nov 10
Consensus revenue estimates increase by 11% The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from RM5.63b to RM6.24b. EPS estimate unchanged from -RM0.31 at last update. Chemicals industry in Malaysia expected to see average net income growth of 25% next year. Consensus price target of RM0.42 unchanged from last update. Share price was steady at RM0.53 over the past week. Reported Earnings • Nov 04
Third quarter 2025 earnings released: RM0.074 loss per share (vs RM0.11 loss in 3Q 2024) Third quarter 2025 results: RM0.074 loss per share (improved from RM0.11 loss in 3Q 2024). Revenue: RM2.45b (up 26% from 3Q 2024). Net loss: RM168.8m (loss narrowed 32% from 3Q 2024). Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings. Announcement • Nov 01
Lotte Chemical Titan Holding Berhad to Report Q3, 2025 Results on Nov 03, 2025 Lotte Chemical Titan Holding Berhad announced that they will report Q3, 2025 results on Nov 03, 2025 Price Target Changed • Aug 17
Price target increased by 9.7% to RM0.43 Up from RM0.40, the current price target is an average from 2 analysts. New target price is 17% below last closing price of RM0.53. Stock is down 49% over the past year. The company is forecast to post a net loss per share of RM0.31 next year compared to a net loss per share of RM0.55 last year. Reported Earnings • Aug 06
Second quarter 2025 earnings released: RM0.076 loss per share (vs RM0.11 loss in 2Q 2024) Second quarter 2025 results: RM0.076 loss per share (improved from RM0.11 loss in 2Q 2024). Revenue: RM1.44b (down 19% from 2Q 2024). Net loss: RM173.1m (loss narrowed 31% from 2Q 2024). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has fallen by 34% per year whereas the company’s share price has fallen by 30% per year. Reported Earnings • Apr 09
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2024 results: RM0.56 loss per share (further deteriorated from RM0.34 loss in FY 2023). Revenue: RM7.44b (down 2.8% from FY 2023). Net loss: RM1.26b (loss widened 62% from FY 2023). Revenue exceeded analyst estimates by 3.9%. Earnings per share (EPS) missed analyst estimates by 38%. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 28 percentage points per year, which is a significant difference in performance. Announcement • Apr 03
Lotte Chemical Titan Holding Berhad, Annual General Meeting, May 05, 2025 Lotte Chemical Titan Holding Berhad, Annual General Meeting, May 05, 2025, at 10:00 Singapore Standard Time. Location: ballroom 1 and 2, level 2, renaissance johor bahru hotel, 2 jalan permas 11, bandar baru permas jaya, 81750 masai, johor darul takzim, Malaysia New Risk • Mar 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risk Share price has been volatile over the past 3 months (7.2% average weekly change). Price Target Changed • Feb 08
Price target decreased by 24% to RM0.75 Down from RM0.99, the current price target is an average from 4 analysts. New target price is 40% above last closing price of RM0.54. Stock is down 55% over the past year. The company is forecast to post a net loss per share of RM0.32 next year compared to a net loss per share of RM0.52 last year. Breakeven Date Change • Feb 07
No longer forecast to breakeven The 4 analysts covering Lotte Chemical Titan Holding Berhad no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of RM77.0m in 2026. New consensus forecast suggests the company will make a loss of RM230.5m in 2026. Board Change • Dec 13
High number of new directors President, CEO & Executive Director Seon Jang was the last director to join the board, commencing their role in 2024. Major Estimate Revision • Nov 13
Consensus EPS estimates fall by 11% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from RM7.68b to RM7.16b. Losses expected to increase from RM0.34 per share to RM0.38. Chemicals industry in Malaysia expected to see average net income growth of 24% next year. Consensus price target down from RM1.08 to RM1.05. Share price fell 17% to RM0.80 over the past week. Reported Earnings • Nov 07
Third quarter 2024 earnings released: RM0.11 loss per share (vs RM0.024 loss in 3Q 2023) Third quarter 2024 results: RM0.11 loss per share (further deteriorated from RM0.024 loss in 3Q 2023). Revenue: RM1.95b (flat on 3Q 2023). Net loss: RM246.4m (loss widened 343% from 3Q 2023). Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 01
Second quarter 2024 earnings released: RM0.11 loss per share (vs RM0.14 loss in 2Q 2023) Second quarter 2024 results: RM0.11 loss per share (improved from RM0.14 loss in 2Q 2023). Revenue: RM1.78b (down 4.3% from 2Q 2023). Net loss: RM248.9m (loss narrowed 21% from 2Q 2023). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance. Price Target Changed • May 03
Price target decreased by 11% to RM0.94 Down from RM1.05, the current price target is an average from 4 analysts. New target price is 13% below last closing price of RM1.07. Stock is down 12% over the past year. The company is forecast to post a net loss per share of RM0.34 next year compared to a net loss per share of RM0.34 last year. Reported Earnings • May 03
First quarter 2024 earnings released: RM2.28 loss per share (vs RM0.099 loss in 1Q 2023) First quarter 2024 results: RM2.28 loss per share. Revenue: RM1.92b (down 2.7% from 1Q 2023). Net loss: RM178.0m (loss narrowed 21% from 1Q 2023). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Chemicals industry in Malaysia. Reported Earnings • Mar 31
Full year 2023 earnings: EPS and revenues exceed analyst expectations Full year 2023 results: RM0.34 loss per share (further deteriorated from RM0.32 loss in FY 2022). Revenue: RM7.65b (down 24% from FY 2022). Net loss: RM780.3m (loss widened 6.7% from FY 2022). Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance. Announcement • Mar 29
Lotte Chemical Titan Holding Berhad, Annual General Meeting, Apr 30, 2024 Lotte Chemical Titan Holding Berhad, Annual General Meeting, Apr 30, 2024, at 10:00 Singapore Standard Time. Agenda: To receive the Audited Financial Statements for the financial year ended 31 December 2023 together with the Reports of the Directors and Auditors thereon; to re-elect the Directors who are retiring pursuant to Clause 100 of the Company's Constitution; to approve the payment of the Directors' Fees for the financial year ending 31 December 2024; to approve the payment of Directors' remuneration and benefits (excluding Directors' Fees) to the Independent Non-Executive Directors up to an amount of RM243,000 with effect from 2024 Annual General Meeting until the next Annual General Meeting of the Company; to appoint Messrs Ernst & Young PLT as Auditors of the Company in place of the retiring Auditors, Messrs KPMG PLT, and to hold office until the conclusion of the next Annual General Meeting at a remuneration to be determined by the Directors; and to consider other matters. Announcement • Mar 07
Lotte Chemical Titan Holding Berhad Announces Resignation of Ong E-Shynn as Joint Secretary Lotte Chemical Titan Holding Berhad announced resignation of Ong E-Shynn as Joint Secretary. Date Of Change 07 March 2024. Major Estimate Revision • Feb 05
Consensus EPS estimates fall by 13% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from RM8.55b to RM7.93b. Losses expected to increase from RM0.30 per share to RM0.34. Chemicals industry in Malaysia expected to see average net income growth of 40% next year. Consensus price target up from RM1.05 to RM1.08. Share price fell 18% to RM1.19 over the past week. New Risk • Jan 31
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Reported Earnings • Jan 30
Full year 2023 earnings released: RM0.34 loss per share (vs RM0.32 loss in FY 2022) Full year 2023 results: RM0.34 loss per share (further deteriorated from RM0.32 loss in FY 2022). Revenue: RM7.65b (down 24% from FY 2022). Net loss: RM780.3m (loss widened 6.7% from FY 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance. Reported Earnings • Oct 27
Third quarter 2023 earnings released: RM0.024 loss per share (vs RM0.16 loss in 3Q 2022) Third quarter 2023 results: RM0.024 loss per share (improved from RM0.16 loss in 3Q 2022). Revenue: RM1.96b (down 17% from 3Q 2022). Net loss: RM55.6m (loss narrowed 84% from 3Q 2022). Revenue is forecast to grow 5.7% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance. Major Estimate Revision • Oct 27
Consensus EPS estimates fall by 28% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from RM7.75b to RM7.57b. Losses expected to increase from RM0.34 per share to RM0.43. Chemicals industry in Malaysia expected to see average net income growth of 29% next year. Consensus price target broadly unchanged at RM1.11. Share price was steady at RM1.14 over the past week. Major Estimate Revision • Aug 03
Consensus revenue estimates fall by 11% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from RM8.71b to RM7.75b. Forecast losses increased from -RM0.141 to -RM0.335 per share. Chemicals industry in Malaysia expected to see average net income growth of 25% next year. Consensus price target down from RM1.17 to RM1.11. Share price fell 8.0% to RM1.15 over the past week. Reported Earnings • Jul 28
Second quarter 2023 earnings released: RM0.14 loss per share (vs RM0.064 loss in 2Q 2022) Second quarter 2023 results: RM0.14 loss per share (further deteriorated from RM0.064 loss in 2Q 2022). Revenue: RM1.86b (down 34% from 2Q 2022). Net loss: RM313.5m (loss widened 115% from 2Q 2022). Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance. Price Target Changed • Jun 20
Price target decreased by 12% to RM1.17 Down from RM1.32, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of RM1.19. Stock is down 39% over the past year. The company is forecast to post a net loss per share of RM0.14 next year compared to a net loss per share of RM0.32 last year. Reported Earnings • Mar 29
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2022 results: RM0.31 loss per share (down from RM0.46 profit in FY 2021). Revenue: RM10.0b (up 1.9% from FY 2021). Net loss: RM714.6m (down 169% from profit in FY 2021). Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates by 135%. Revenue is forecast to stay flat during the next 3 years compared to a 3.7% growth forecast for the Chemicals industry in Malaysia. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Board Change • Feb 02
High number of new directors Executive VP of Manufacturing & Non-Independent Director Young Moon was the last director to join the board, commencing their role in the last week. Reported Earnings • Feb 01
Full year 2022 earnings released: RM0.31 loss per share (vs RM0.46 profit in FY 2021) Full year 2022 results: RM0.31 loss per share (down from RM0.46 profit in FY 2021). Revenue: RM10.0b (up 1.9% from FY 2021). Net loss: RM714.6m (down 169% from profit in FY 2021). Revenue is expected to decline by 4.6% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Malaysia are expected to grow by 6.1%. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Dec 01
Upcoming dividend of RM0.14 per share Eligible shareholders must have bought the stock before 08 December 2022. Payment date: 29 December 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 13%. Within top quartile of Malaysian dividend payers (5.1%). Higher than average of industry peers (5.6%). Announcement • Nov 25
Lotte Chemical Titan Holding Berhad Declares Special Single Tier Dividend for the Financing Year Ending 31 December 2022, Payable on 29 December 2022 The Board of Directors of Lotte Chemical Titan Holding Berhad has declared a special single tier dividend of 13.98 sen per share for the financing year ending 31 December 2022 out of the retained earnings. This special dividend will be payable on 29 December 2022. Price Target Changed • Nov 16
Price target decreased to RM1.46 Down from RM1.77, the current price target is an average from 7 analysts. New target price is 15% above last closing price of RM1.27. Stock is down 47% over the past year. The company is forecast to post a net loss per share of RM0.13 compared to earnings per share of RM0.46 last year. Price Target Changed • Nov 01
Price target decreased to RM1.55 Down from RM1.77, the current price target is an average from 7 analysts. New target price is 19% above last closing price of RM1.31. Stock is down 51% over the past year. The company is forecast to post a net loss per share of RM0.13 compared to earnings per share of RM0.46 last year. Announcement • Oct 28
Lotte Chemical Titan Holding Berhad Announces Appointment of ONG E-SHYNN as Joint Secretary Lotte Chemical Titan Holding Berhad announced appointment of ONG E-SHYNN as Joint Secretary. Reported Earnings • Oct 28
Third quarter 2022 earnings released: RM0.16 loss per share (vs RM0.021 profit in 3Q 2021) Third quarter 2022 results: RM0.16 loss per share (down from RM0.021 profit in 3Q 2021). Revenue: RM2.37b (up 6.2% from 3Q 2021). Net loss: RM355.5m (down RM404.3m from profit in 3Q 2021). Revenue is expected to decline by 2.8% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Malaysia are expected to grow by 1.8%. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment deteriorated over the past week After last week's 18% share price decline to RM1.34, the stock trades at a trailing P/E ratio of 17.4x. Average forward P/E is 10x in the Chemicals industry in Malaysia. Total loss to shareholders of 37% over the past three years. Major Estimate Revision • Aug 04
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from RM10.4b to RM10.7b. Now expected to report loss of -RM0.03 instead of RM0.10 per share profit. Chemicals industry in Malaysia expected to see average net income decline 1.2% next year. Consensus price target down from RM2.07 to RM1.87. Share price fell 10.0% to RM1.81 over the past week. Reported Earnings • Jul 29
Second quarter 2022 earnings released: RM0.064 loss per share (vs RM0.17 profit in 2Q 2021) Second quarter 2022 results: RM0.064 loss per share (down from RM0.17 profit in 2Q 2021). Revenue: RM2.82b (up 11% from 2Q 2021). Net loss: RM145.9m (down 138% from profit in 2Q 2021). Over the next year, revenue is expected to shrink by 3.4% compared to a 11% growth forecast for the industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Announcement • May 19
Lotte Chemical Titan Holding Berhad Announces Resignation of Lim Yoke Ping as Joint Secretary. Effective from May 18, 2022 Lotte Chemical Titan Holding Berhad announced resignation of Lim Yoke Ping as Joint Secretary. Effective from May 18, 2022. Major Estimate Revision • May 05
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from RM9.57b to RM10.1b. EPS estimate fell from RM0.13 to RM0.11 per share. Net income forecast to shrink 65% next year vs 20% growth forecast for Chemicals industry in Malaysia . Consensus price target down from RM2.19 to RM2.07. Share price fell 2.3% to RM2.17 over the past week. Reported Earnings • Apr 29
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: EPS: RM0.046 (down from RM0.19 in 1Q 2021). Revenue: RM2.76b (up 17% from 1Q 2021). Net income: RM104.0m (down 76% from 1Q 2021). Profit margin: 3.8% (down from 19% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) also missed analyst estimates by 1.6%. Over the next year, revenue is expected to shrink by 4.7% compared to a 24% growth forecast for the industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Price Target Changed • Apr 27
Price target decreased to RM2.19 Down from RM2.77, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of RM2.26. Stock is down 24% over the past year. The company is forecast to post earnings per share of RM0.13 for next year compared to RM0.46 last year. Reported Earnings • Mar 30
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: RM0.47 (up from RM0.065 in FY 2020). Revenue: RM9.83b (up 42% from FY 2020). Net income: RM1.06b (up RM909.4m from FY 2020). Profit margin: 11% (up from 2.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) also missed analyst estimates by 1.6%. Over the next year, revenue is expected to shrink by 1.1% compared to a 27% growth forecast for the industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. Upcoming Dividend • Mar 14
Upcoming dividend of RM0.21 per share Eligible shareholders must have bought the stock before 21 March 2022. Payment date: 13 April 2022. Payout ratio is a comfortable 45% and this is well supported by cash flows. Trailing yield: 8.9%. Within top quartile of Malaysian dividend payers (4.7%). Higher than average of industry peers (4.7%). Announcement • Mar 04
Lotte Chemical Titan Holding Berhad Declares Dividend for the Financial Year Ended 2021, Payable on April 13, 2022 Lotte Chemical Titan Holding Berhad declared 21 sen dividend per share, which translates to total dividend payout of MYR 478.3 million for financial year ended 2021 Payable on April 13, 2022. Announcement • Feb 26
An unknown buyer acquired 10% stake in Lotte UBE Synthetic Rubber Sdn Bhd from Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN). An unknown buyer acquired 10% stake in Lotte UBE Synthetic Rubber Sdn Bhd from Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN) in December 2021.
An unknown buyer completed the acquisition of 10% stake in Lotte UBE Synthetic Rubber Sdn Bhd from Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN) in December 2021. Price Target Changed • Jan 28
Price target decreased to RM2.51 Down from RM2.77, the current price target is an average from 7 analysts. New target price is 11% above last closing price of RM2.26. Stock is down 4.6% over the past year. The company is forecast to post earnings per share of RM0.18 for next year compared to RM0.46 last year. Reported Earnings • Jan 28
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: RM0.47 (up from RM0.065 in FY 2020). Revenue: RM9.83b (up 42% from FY 2020). Net income: RM1.06b (up RM909.4m from FY 2020). Profit margin: 11% (up from 2.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 100%. Earnings per share (EPS) also missed analyst estimates by 100%. Over the next year, revenue is expected to shrink by 4.0% compared to a 26% growth forecast for the industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Upcoming Dividend • Nov 05
Upcoming dividend of RM0.18 per share Eligible shareholders must have bought the stock before 12 November 2021. Payment date: 26 November 2021. Trailing yield: 1.2%. Lower than top quartile of Malaysian dividend payers (4.2%). Lower than average of industry peers (3.2%). Reported Earnings • Oct 29
Third quarter 2021 earnings released: EPS RM0.021 (vs RM0.035 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: RM2.24b (up 15% from 3Q 2020). Net income: RM48.8m (down 38% from 3Q 2020). Profit margin: 2.2% (down from 4.1% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Reported Earnings • Jul 29
Second quarter 2021 earnings released: EPS RM0.17 (vs RM0.039 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: RM2.54b (up 61% from 2Q 2020). Net income: RM382.3m (up 331% from 2Q 2020). Profit margin: 15% (up from 5.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings. Price Target Changed • Jul 29
Price target decreased to RM3.24 Down from RM3.72, the current price target is an average from 7 analysts. New target price is 21% above last closing price of RM2.69. Stock is up 35% over the past year.